Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial – ANZGOG 0903 - Concepedia

Concepedia

Publication | Closed Access

Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial – ANZGOG 0903

54

Citations

19

References

2019

Year

Linda Mileshkin, Richard J. Edmondson, Rachel O’Connell, Katrin Marie Sjoquist, John Andrews, R. Jyothirmayi, Philip Beale, Tony Bonaventura, Jeffrey C. Goh, Marcia Hall,

Gynecologic Oncology

Positive Endometrial CancerMedicineUterine ReceptivityPharmacologyGynecologyRecurrent EstrogenPhase 2OncologyEndocrine-related CancerMenopause Hormone Therapy

References

	Year	Citations

Page 1

Page 1